Correlation Between Viracta Therapeutics and OrganiGram Holdings
Can any of the company-specific risk be diversified away by investing in both Viracta Therapeutics and OrganiGram Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viracta Therapeutics and OrganiGram Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viracta Therapeutics and OrganiGram Holdings, you can compare the effects of market volatilities on Viracta Therapeutics and OrganiGram Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viracta Therapeutics with a short position of OrganiGram Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viracta Therapeutics and OrganiGram Holdings.
Diversification Opportunities for Viracta Therapeutics and OrganiGram Holdings
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Viracta and OrganiGram is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Viracta Therapeutics and OrganiGram Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OrganiGram Holdings and Viracta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viracta Therapeutics are associated (or correlated) with OrganiGram Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OrganiGram Holdings has no effect on the direction of Viracta Therapeutics i.e., Viracta Therapeutics and OrganiGram Holdings go up and down completely randomly.
Pair Corralation between Viracta Therapeutics and OrganiGram Holdings
Given the investment horizon of 90 days Viracta Therapeutics is expected to under-perform the OrganiGram Holdings. In addition to that, Viracta Therapeutics is 1.38 times more volatile than OrganiGram Holdings. It trades about -0.44 of its total potential returns per unit of risk. OrganiGram Holdings is currently generating about -0.25 per unit of volatility. If you would invest 183.00 in OrganiGram Holdings on August 24, 2024 and sell it today you would lose (32.00) from holding OrganiGram Holdings or give up 17.49% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Viracta Therapeutics vs. OrganiGram Holdings
Performance |
Timeline |
Viracta Therapeutics |
OrganiGram Holdings |
Viracta Therapeutics and OrganiGram Holdings Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Viracta Therapeutics and OrganiGram Holdings
The main advantage of trading using opposite Viracta Therapeutics and OrganiGram Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viracta Therapeutics position performs unexpectedly, OrganiGram Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OrganiGram Holdings will offset losses from the drop in OrganiGram Holdings' long position.Viracta Therapeutics vs. ZyVersa Therapeutics | Viracta Therapeutics vs. Sonnet Biotherapeutics Holdings | Viracta Therapeutics vs. Zura Bio Limited | Viracta Therapeutics vs. Phio Pharmaceuticals Corp |
OrganiGram Holdings vs. Cronos Group | OrganiGram Holdings vs. Aurora Cannabis | OrganiGram Holdings vs. SNDL Inc | OrganiGram Holdings vs. Canopy Growth Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |